Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,789 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $495.68 | 9 | $0 (2023) |
| Kestra Medical Technology Services, Inc. | $249.13 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $222.26 | 6 | $0 (2023) |
| Medtronic, Inc. | $140.59 | 1 | $0 (2023) |
| Penumbra, Inc. | $130.85 | 1 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $121.95 | 2 | $0 (2024) |
| PFIZER INC. | $97.36 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $91.21 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $75.00 | 1 | $0 (2023) |
| Ethicon US, LLC | $72.05 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $481.82 | 11 | Kestra Medical Technology Services, Inc. ($171.10) |
| 2023 | $716.26 | 18 | AstraZeneca Pharmaceuticals LP ($162.39) |
| 2022 | $562.44 | 13 | E.R. Squibb & Sons, L.L.C. ($392.32) |
| 2021 | $28.81 | 1 | Mylan Specialty L.P. ($28.81) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $81.04 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Musculoskeletal Transplant Foundation Inc. | — | Food and Beverage | In-kind items and services | $4.70 | General |
| 08/14/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Cardiology | ||||||
| 06/24/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $96.98 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Cardiology | ||||||
| 05/06/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $130.85 | General |
| Category: Peripheral Intervention | ||||||
| 05/02/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.16 | General |
| Category: Cardiology | ||||||
| 02/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: Cardiology | ||||||
| 02/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $25.79 | General |
| Category: Cardiology | ||||||
| 01/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/21/2023 | Ethicon US, LLC | Echelon Circular (Device) | Food and Beverage | In-kind items and services | $42.35 | General |
| Category: Endo-Mechanical | ||||||
| 09/21/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.32 | General |
| Category: Cardiology | ||||||
| 08/09/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/28/2023 | Ethicon US, LLC | Echelon Circular (Device) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Endo-Mechanical | ||||||
| 07/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Cardiovascular | ||||||
| 07/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $28.37 | General |
| Category: Cardiovascular | ||||||
| 06/28/2023 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 06/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Cardiology | ||||||
| 04/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 04/04/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 829 | 1,772 | $540,760 | $142,641 |
| 2022 | 6 | 845 | 1,738 | $494,992 | $131,522 |
| 2021 | 3 | 228 | 531 | $142,775 | $40,684 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 410 | 1,325 | $357,750 | $94,974 | 26.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 264 | 283 | $111,219 | $29,178 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 127 | 127 | $56,769 | $14,469 | 25.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 37 | $15,022 | $4,019 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 390 | 1,251 | $306,495 | $80,864 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 280 | 299 | $107,341 | $28,995 | 27.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 125 | 127 | $59,563 | $15,872 | 26.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 29 | $10,179 | $2,769 | 27.2% |
| 99235 | Hospital observation or inpatient care admitted and discharged on the same day for moderate severity problem, typically 50 minutes | Facility | 2022 | 11 | 11 | $6,248 | $1,684 | 27.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 21 | 21 | $5,166 | $1,337 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 117 | 417 | $98,829 | $28,148 | 28.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 72 | 74 | $25,826 | $7,407 | 28.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 39 | 40 | $18,120 | $5,128 | 28.3% |
About Dr. Michael Chen, MD
Dr. Michael Chen, MD is a Internal Medicine healthcare provider based in Roslyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1730686296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chen, MD has received a total of $1,789 in payments from pharmaceutical and medical device companies, with $481.82 received in 2024. These payments were reported across 43 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,789).
As a Medicare-enrolled provider, Chen has provided services to 1,902 Medicare beneficiaries, totaling 4,041 services with total Medicare billing of $314,846. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Roslyn, NY
- Active Since 04/11/2018
- Last Updated 05/03/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730686296
Products in Payments
- CAMZYOS (Drug) $363.35
- Assure WCD (Device) $249.13
- ELIQUIS (Drug) $199.69
- BRILINTA (Drug) $166.52
- AZURE XT DR MRI SURESCAN (Device) $140.59
- Indigo System (Device) $130.85
- Inpefa (Drug) $121.95
- ENTRESTO (Drug) $91.21
- XARELTO (Drug) $75.00
- Echelon Circular (Device) $72.05
- FARXIGA (Drug) $55.74
- YUPELRI (Drug) $28.81
- FUROSCIX (Drug) $24.21
- WATCHMAN Access System (Device) $19.04
- CALDOLOR (Drug) $16.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roslyn
Dr. Rita Jermyn, Md, MD
Internal Medicine — Payments: $196,454
Joshua Stern, M.d, M.D
Internal Medicine — Payments: $116,680
Dr. Xiao Li Ren, M.d, M.D
Internal Medicine — Payments: $4,848
Ryan Murphy, D.o, D.O
Internal Medicine — Payments: $3,485
Natalia Hochbaum, M.d, M.D
Internal Medicine — Payments: $3,414
Dr. Stephen Mezzafonte, M.d, M.D
Internal Medicine — Payments: $2,725